Early Access — free while we kick the tires
EdgarHawk

Culpepper Glenn

Director

Director
4 filings analyzed · 1 company · Latest 2026-03-18

Companies

Company Buys Sells Direction
Quest Resource Holding Corp QRHC 4 0 Net buying

Activity

March 2026
low
Buy
5,000 shares
$5,800
Significance 3/10

Director Culpepper Glenn buys 5,000 shares of QRHC at $1.16; stock now at $0.88, -71.2% from 52-week high, -61.4% in 90 days.

Culpepper Glenn, a director of Quest Resource Holding Corp, purchased 5,000 shares at $1.16 on 2026-03-16, increasing his holdings from 56.6K to 61.6K shares. The transaction occurred at a time when the stock was trading 71.2% below its 52-week high of $3.05 and has since declined further to $0.88, a 24.1% drop in approximately two weeks. The company is currently unprofitable with a negative net income of $1.3M on quarterly revenue of $63.3M, and annual revenue declined 13.3% year-over-year, signaling operational stress. His prior four trades at this ticker show a 0% win rate on 90-day returns, with an average 90-day outcome of approximately -22.8%, suggesting his recent buys have not preceded recoveries in the stock.

December 2025
medium
Buy
5,000 shares
$9,800
Significance 3/10

Director Glenn Culpepper bought 5,000 shares of QRHC at $1.96 on 2025-12-23; stock now at $1.95, down 70.0% from 52-week high.

Culpepper Glenn, a director of Quest Resource Holding Corp, purchased 5,000 shares at $1.96 on 2025-12-23, increasing his holdings to 56.6K shares and representing a +9.7% increase in his position. The stock is currently trading at $1.95, down 70.0% from its 52-week high of $6.50, while the company posted a negative net income of $-1.3M against revenue of $63.3M in its latest quarter and has zero annual revenue growth. His prior three purchases at this ticker (most recently on 2025-08-14, 2024-12-23, and 2024-05-16) all proved disadvantageous within 90 days, with outcomes of -8.9%, -51.8%, and -17.7% respectively, establishing a 0 of 3 success rate on timing at this ticker. The sequence of accumulation into a depressed and unprofitable security warrants examination of whether this transaction signals conviction or reflects a pattern of poorly-timed entry decisions.

August 2025
low
Buy
5,000 shares
$8,395
Significance 3/10

Director Culpepper Glenn buys 5,000 shares of QRHC at $1.68; stock down -81.4% from 52-week high of $9.04.

Culpepper Glenn purchased 5,000 shares at $1.68 on 2025-08-14, increasing his holdings to 51.6K shares (+10.7% from 46.6K). The stock is trading -81.4% below its 52-week high and has declined -16.8% over 30 days and -27.9% over 90 days. Glenn's prior trades at QRHC show weak execution: a December 2024 buy resulted in a -51.8% 90-day return, and a May 2024 buy resulted in a -17.7% 90-day return, with 0 of 2 prior buys well-timed at the 90-day mark. The company reported unprofitable operations with $-2.0M net income in the latest quarter and zero annual revenue growth. The pattern of repeated purchases into a declining stock coupled with poor historical timing outcomes and deteriorating fundamentals suggests limited conviction signals from this transaction.

December 2024
low
Buy
2,000 shares
$11,700
Significance 4/10

Director Culpepper Glenn bought 2,000 shares of QRHC at $5.85 on 2024-12-23, raising stake to 6,000 shares; stock now -41.8% from 52-week high.

Director Culpepper Glenn purchased 2,000 shares at $5.85, increasing his holdings by 50.0% to 6,000 shares post-transaction. The purchase occurred near the 52-week low ($5.85 trading level), but the stock has declined 41.8% from its 52-week high of $10.66 and is down 14.1% over the prior 30 days. Glenn's cross-ticker track record shows a prior buy with an average 90-day return of -17.7%, and his only prior QRHC transaction (a buy on 2024-05-16) also posted a 90-day return of -17.7%, with zero well-timed buys at the 90-day mark. The company reported unprofitable operations with net income of $-3.4M on revenue of $72.8M and annual growth of just +1.5%, indicating financial headwinds. While the transaction reflects an open-market accumulation, the combination of persistent underperformance in Glenn's prior trades at this ticker, the company's negative profitability, and continued price deterioration after the purchase suggests this transaction has not yet validated as a well-timed entry point.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access